Research suggests that increased expression of the prss56 gene may contribute to the development of high myopia in humans, potentially making it a target for therapy. Studies have identified variants of genes, including prss56, in individuals with high myopia and related conditions. The genetic and epigenetic factors underlying high myopia are being investigated, with findings implicating multiple genes and pathways in its pathogenesis.